Panter; Samuel Scott

Patent Applications and Registrations

Patent applications and USPTO patent grants for Panter; Samuel Scott.The latest application filed is for "method of treating stroke comprising administering metal chelators to the upper one-third of the nasal cavity".

Company Profile

0.15.12

Panter; Samuel Scott - San Francisco CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method of pre-treating patients for stroke comprising administering metal chelators to the upper one-third of the nasal cavity Grant 9,801,835 - Frey, II , et al. October 31, 2	2017-10-31
Method of treating cerebral hemorrhage and subarachnoid hemorrhage comprising administering metal chelators to the upper one-third of the nasal cavity Grant 9,707,193 - Frey, II , et al. July 18, 2	2017-07-18
Method of treating spinal cord injury comprising administering metal chelators to the upper one-third of the nasal cavity Grant 9,636,313 - Frey, II , et al. May 2, 2	2017-05-02
Method of treating traumatic brain injury/head injury comprising administering metal chelators to the upper one-third of the nasal cavity Grant 9,636,312 - Frey, II , et al. May 2, 2	2017-05-02
Method of treating progressive supranuclear palsy comprising administering metal chelators to the upper one-third of the nasal cavity Grant 9,629,819 - Frey, II , et al. April 25, 2	2017-04-25
Pharmaceutical compositions for treatment of patients with neurodegeneration following ischemic insult Grant 9,351,927 - Frey, II , et al. May 31, 2	2016-05-31
Method of treating stroke comprising administering metal chelators to the upper one-third of the nasal cavity Grant 9,345,676 - Frey, II , et al. May 24, 2	2016-05-24
Methods of treating Huntington's disease comprising administering metal chelators to the upper one-third of the nasal cavity Grant 9,216,161 - Frey, II , et al. December 22, 2	2015-12-22
Method of treating lewy body syndrome comprising administering metal chelators to the upper one-third of the nasal cavity Grant 9,211,272 - Frey, II , et al. December 15, 2	2015-12-15
Methods of treating neurodegeneration caused by iron accumulation in the brain comprising administering metal chelators to the upper one-third of the nasal cavity Grant 9,211,273 - Frey, II , et al. December 15, 2	2015-12-15
Method of treating parkinson's disease comprising administering deferoxamine (DFO) to the upper one-third of the nasal cavity Grant 9,205,066 - Hanson, II , et al. December 8, 2	2015-12-08
Method Of Treating Stroke Comprising Administering Metal Chelators To The Upper One-third Of The Nasal Cavity App 20140213655 - Frey II; William H. ; et al.	2014-07-31
Methods Of Treating Neurodegeneration Caused By Iron Accumulation In The Brain Comprising Administering Metal Chelators To The Upper One-third Of The Nasal Cavity App 20140179793 - Frey, II; William H. ; et al.	2014-06-26
Method Of Pre-treating Patients For Stroke Comprising Administering Metal Chelators To The Upper One-third Of The Nasal Cavity App 20140179788 - Frey, II; William H. ; et al.	2014-06-26
Method Of Treating Progressive Supranuclear Palsy Comprising Administering Metal Chelators To The Upper One-third Of The Nasal Cavity App 20140179791 - Frey, II; William H. ; et al.	2014-06-26
Method Of Treating Traumatic Brain Injury/head Injury Comprising Administering Metal Chelators To The Upper One-third Of The Nasal Cavity App 20140179790 - Frey, II; William H. ; et al.	2014-06-26
Method Of Treating Spinal Cord Injury Comprising Administering Metal Chelators To The Upper One-third Of The Nasal Cavity App 20140179787 - Frey, II; William H. ; et al.	2014-06-26
Method Of Treating Lewy Body Syndrome With Comprising Administering Metal Chelators To The Upper One-third Of The Nasal Cavity App 20140179792 - Frey, II; William H. ; et al.	2014-06-26
Methods Of Treating Huntington's Disease Comprising Administering Metal Chelators To The Upper One-third Of The Nasal Cavity App 20140179789 - Frey, II; William H. ; et al.	2014-06-26
Method Of Treating Cerebral Hemorrhage And Subarachnoid Hemorrhage Comprising Administering Metal Chelators To The Upper One-third Of The Nasal Cavity App 20140178331 - Frey II; William H. ; et al.	2014-06-26
Method Of Treating Parkinson's Disease Comprising Administering Deferoxamine (dfo) To The Upper One-third Of The Nasal Cavity App 20140171508 - Hanson, II; Leah Ranae Bresin ; et al.	2014-06-19
Methods for providing neuroprotection for the animal central nervous system against the effects of ischemia, neurodegeneration, trauma, and metal poisoning Grant 8,568,691 - Frey, II , et al. October 29, 2	2013-10-29
Methods And Pharmaceutical Compositions For Differentially Altering Gene Expression To Provide Neuroprotection For The Animal Central Nervous System Against The Effects Of Ischemia, Neurodegeneration, Trauma And Metal Poisoning App 20100267834 - Frey, II; William H. ; et al.	2010-10-21
Method of treating Alzheimer's disease comprising administering deferoxamine (DFO) to the upper one-third of the nasal cavity Grant 7,776,312 - Frey, II , et al. August 17, 2	2010-08-17
Methods For Providing Neuroprotection For The Animal Central Nervous System Against The Effects Of Ischemia, Neurodegeneration, Trauma, And Metal Poisoning App 20100061959 - Frey II; William H. ; et al.	2010-03-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.